Not long after a first-of-its-kind blood test received approval to evaluate patients with mild traumatic brain injury, headlines dubbed it a “concussion test.” But experts in biomarkers are clarifying certain misconceptions about what the test can and can’t reveal.
“It’s used to rule out the need for a [computed tomography] scan within 12 hours” after a suspected mild traumatic brain injury (TBI), said Steven Richieri, MBA, president and chief operating officer of San Diego-based Banyan Biomarkers Inc, which developed the test.
No comments:
Post a Comment